|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/422 | |
| A61P 9/00 | |||
| A61P 43/00 | |||
| A61K 9/00 | |||
| A61K 9/20 | |||
| A61K 9/48 |
| (11) | Number of the document | 3142655 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15792047.1 |
| Date of filing the European patent application | 2015-05-18 | |
| (97) | Date of publication of the European application | 2017-03-22 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/031395 |
| Date | 2015-05-18 |
| (87) | Number | WO 2015/176060 |
| Date | 2015-11-19 |
| (30) | Number | Date | Country code |
| 201461994436 P | 2014-05-16 | US | |
| 201462060198 P | 2014-10-06 | US | |
| 201462078649 P | 2014-11-12 | US | |
| 201562118896 P | 2015-02-20 | US |
| (72) |
PAVLIV, Leo, US
VOSS, Bryan, US
WEST, James, US
CARRIER, Erica, US
|
| (73) |
Cumberland Pharmaceuticals Inc.,
2525 West End Avenue Suite 950, Nashville, TN 37203,
US
Vanderbilt University, 305 Kirkland Hall 2201 West End Avenue, Nashville, TN 37235, US |
| (54) | COMPOSITIONS AND METHODS OF TREATING CARDIAC FIBROSIS WITH IFETROBAN |
| COMPOSITIONS AND METHODS OF TREATING CARDIAC FIBROSIS WITH IFETROBAN |